BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 29224265)

  • 1. [Analysis on the clinical therapeutic effects of arterial first approach pancreatoduodenectomy in the treatment of borderline resectable pancreatic adenocarcinoma].
    Jin G; Zheng KL; Guo SW; Shao Z; Liu C; Shi XH; Liu RD; Bai SJ; Jiang H; Bian Y; Hu XG
    Zhonghua Wai Ke Za Zhi; 2017 Dec; 55(12):909-915. PubMed ID: 29224265
    [No Abstract]   [Full Text] [Related]  

  • 2. Standard versus extended pancreaticoduodenectomy in treating adenocarcinoma of the head of the pancreas.
    Gong J; Mai G; Zheng ZJ; Xiang GM; Hu WM; Tian BL; Zhang ZD; Liu XB
    Chin Med Sci J; 2013 Jun; 28(2):107-12. PubMed ID: 23806374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does the Artery-first Approach Improve the Rate of R0 Resection in Pancreatoduodenectomy?: A Multicenter, Randomized, Controlled Trial.
    Sabater L; Cugat E; Serrablo A; Suarez-Artacho G; Diez-Valladares L; Santoyo-Santoyo J; Martín-Pérez E; Ausania F; Lopez-Ben S; Jover-Navalon JM; Garcés-Albir M; Garcia-Domingo MI; Serradilla M; Pérez-Aguirre E; Sánchez-Pérez B; Di Martino M; Senra-Del-Rio P; Falgueras-Verdaguer L; Carabias A; Gómez-Mateo MC; Ferrandez A; Dorcaratto D; Muñoz-Forner E; Fondevila C; Padillo J
    Ann Surg; 2019 Nov; 270(5):738-746. PubMed ID: 31498183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.
    Raut CP; Tseng JF; Sun CC; Wang H; Wolff RA; Crane CH; Hwang R; Vauthey JN; Abdalla EK; Lee JE; Pisters PW; Evans DB
    Ann Surg; 2007 Jul; 246(1):52-60. PubMed ID: 17592291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior Superior Mesenteric Artery (SMA) First Approach vs. Standard Pancreaticoduodenectomy in Patients with Resectable Periampullary Cancers: a Prospective Comparison Focusing on Circumferential Resection Margins.
    Pal S; George J; Singh AN; Mathur S; Dash NR; Garg P; Sahni P; Chattopadhyay TK
    J Gastrointest Cancer; 2018 Sep; 49(3):252-259. PubMed ID: 28315190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein resection in borderline resectable pancreatic cancer: a United Kingdom multicenter study.
    Ravikumar R; Sabin C; Abu Hilal M; Bramhall S; White S; Wigmore S; Imber CJ; Fusai G;
    J Am Coll Surg; 2014 Mar; 218(3):401-11. PubMed ID: 24484730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAPLE-PD trial (Mesenteric Approach vs. Conventional Approach for Pancreatic Cancer during Pancreaticoduodenectomy): study protocol for a multicenter randomized controlled trial of 354 patients with pancreatic ductal adenocarcinoma.
    Hirono S; Kawai M; Okada KI; Fujii T; Sho M; Satoi S; Amano R; Eguchi H; Mataki Y; Nakamura M; Matsumoto I; Baba H; Tani M; Kawabata Y; Nagakawa Y; Yamada S; Murakami Y; Shimokawa T; Yamaue H
    Trials; 2018 Nov; 19(1):613. PubMed ID: 30409152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis.
    Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC
    Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete Lymphadenectomy Around the Entire Superior Mesenteric Artery Improves Survival in Artery-First Approach Pancreatoduodenectomy for T3 Pancreatic Ductal Adenocarcinoma.
    Kobayashi S; Otsubo T; Nakano H; Koizumi S; Nakahara K
    World J Surg; 2021 Mar; 45(3):857-864. PubMed ID: 33174091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma.
    Farnell MB; Pearson RK; Sarr MG; DiMagno EP; Burgart LJ; Dahl TR; Foster N; Sargent DJ;
    Surgery; 2005 Oct; 138(4):618-28; discussion 628-30. PubMed ID: 16269290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of vascular resection in pancreaticoduodenectomy: single-surgeon experience.
    Menon VG; Puri VC; Annamalai AA; Tuli R; Nissen NN
    Am Surg; 2013 Oct; 79(10):1064-7. PubMed ID: 24160800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma.
    Pendurthi TK; Hoffman JP; Ross E; Johnson DE; Eisenberg BL
    Am Surg; 1998 Jul; 64(7):686-92. PubMed ID: 9655283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma.
    Kawabata Y; Tanaka T; Nishi T; Monma H; Yano S; Tajima Y
    Eur J Surg Oncol; 2012 Jul; 38(7):574-9. PubMed ID: 22575529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical impacts of resection margin status and clinicopathologic parameters on pancreatic ductal adenocarcinoma.
    Jamiyan T; Shiraki T; Kurata Y; Ichinose M; Kubota K; Imai Y
    World J Surg Oncol; 2020 Jun; 18(1):137. PubMed ID: 32571348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The Efficacy of 17 Cases of Pancreaticoduodenectomy Combined with Vascular Resection and Reconstruction by Using Robotic Operation System (with Video)].
    Yang JR; Chen MM; Deng XX; Qin K; Shi YS; Zhang JQ; Cheng DF; Jin JB; Peng CH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 51(4):462-466. PubMed ID: 32691551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer: An intention to treat analysis.
    Barenboim A; Lahat G; Geva R; Nachmany I; Nakache R; Goykhman Y; Brazowski E; Rosen G; Isakov O; Wolf I; Klausner JM; Lubezky N
    Eur J Surg Oncol; 2018 Oct; 44(10):1619-1623. PubMed ID: 30146251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inferior Infracolic 'Superior Mesenteric Artery First' Approach with a No-Touch Isolation Surgical Technique in Patients with a Borderline Resectable Cancer of the Pancreatic Head.
    Zhu J; Han D; Li X; Pan F; Ma J; Kou J; Fan H; Lang R; He Q
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):976-980. PubMed ID: 27600620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreaticoduodenectomy with vascular resection: margin status and survival duration.
    Tseng JF; Raut CP; Lee JE; Pisters PW; Vauthey JN; Abdalla EK; Gomez HF; Sun CC; Crane CH; Wolff RA; Evans DB
    J Gastrointest Surg; 2004 Dec; 8(8):935-49; discussion 949-50. PubMed ID: 15585381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic pancreaticoduodenectomy for tumors of the head of pancreas; 10 cases for a single center experience.
    Caruso F; Alessandri G; Cesana G; Castello G; Uccelli M; Ciccarese F; Giorgi R; Villa R; Scotto B; Olmi S
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3745-3753. PubMed ID: 28975996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional pancreatoduodenectomy versus standard pancreatoduodenectomy with portal vein resection for pancreatic ductal adenocarcinoma with portal vein invasion.
    Oba A; Ito H; Ono Y; Sato T; Mise Y; Inoue Y; Takahashi Y; Saiura A
    BJS Open; 2020 Jun; 4(3):438-448. PubMed ID: 32191395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.